These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1609168)
41. Seasonal influenza: an overview. Li C; Freedman M J Sch Nurs; 2009 Feb; 25 Suppl 1():4S-12S. PubMed ID: 19197008 [TBL] [Abstract][Full Text] [Related]
42. National Advisory Committee on Immunization (NACI) statement on influenza vaccination for the 1995-96 season. Can Commun Dis Rep; 1995 Jun; 21(12):105-13. PubMed ID: 7647747 [No Abstract] [Full Text] [Related]
43. Influenza and influenza vaccination. Goodman RA; Hinman AR; Nolan TF; Brandling-Bennett AD Am Fam Physician; 1980 Jan; 21(1):101-5. PubMed ID: 7350730 [TBL] [Abstract][Full Text] [Related]
44. New developments in influenza vaccine technology: a potential new prevention strategy for employers and managed care organizations. Williams JP; Lednar W Am J Manag Care; 2002 Apr; 8(5 Suppl):S143-54. PubMed ID: 11999801 [TBL] [Abstract][Full Text] [Related]
45. Influenza vaccination coverage among children with high-risk medical conditions. Esposito S; Marchisio P; Droghetti R; Lambertini L; Faelli N; Bosis S; Tosi S; Begliatti E; Principi N Vaccine; 2006 Jun; 24(24):5251-5. PubMed ID: 16621177 [TBL] [Abstract][Full Text] [Related]
46. Update on influenza A (H1N1) 2009 monovalent vaccines. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398 [TBL] [Abstract][Full Text] [Related]
47. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279 [TBL] [Abstract][Full Text] [Related]
48. Preventing influenza and its complications: a public health initiative for the year 2000. Reece SM Nurse Pract; 1995 Sep; 20(9):32-6, 44. PubMed ID: 7501314 [TBL] [Abstract][Full Text] [Related]
50. Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers. de Bruijn IA; Nauta J; Gerez L; Palache AM Virus Res; 2004 Jul; 103(1-2):139-45. PubMed ID: 15163502 [TBL] [Abstract][Full Text] [Related]
52. With H1N1 vaccine shortage expected, highest-risk groups go to front of line. Who is at risk for serious infections and why? AIDS Alert; 2009 Oct; 24(10):suppl 1-2. PubMed ID: 20034142 [No Abstract] [Full Text] [Related]
53. Background and recommendations for influenza vaccine administration 1978-1979 season. Raff MJ; Melo JC J Ky Med Assoc; 1978 Nov; 76(11):564-6. PubMed ID: 701969 [No Abstract] [Full Text] [Related]
54. [The concept of risk in influenza (author's transl)]. Hannoun C Rev Epidemiol Sante Publique; 1976; 24(3-4):241-51. PubMed ID: 1005853 [TBL] [Abstract][Full Text] [Related]
55. [Problems of influenza immunization and it's future]. Kamiya H Nihon Rinsho; 2000 Nov; 58(11):2192-7. PubMed ID: 11225303 [TBL] [Abstract][Full Text] [Related]